Raymond James Financial Services Advisors’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.48M Buy
37,668
+4,671
+14% +$432K ﹤0.01% 1427
2024
Q2
$3.56M Sell
32,997
-3,932
-11% -$424K 0.01% 1344
2024
Q1
$3.5M Buy
36,929
+2,884
+8% +$274K 0.01% 1336
2023
Q4
$3.14M Sell
34,045
-8,664
-20% -$799K 0.01% 1326
2023
Q3
$2.14M Sell
42,709
-18,938
-31% -$951K ﹤0.01% 1467
2023
Q2
$3.9M Buy
61,647
+26,292
+74% +$1.66M 0.01% 1155
2023
Q1
$1.59M Sell
35,355
-298
-0.8% -$13.4K ﹤0.01% 1624
2022
Q4
$1.56M Sell
35,653
-8,533
-19% -$374K ﹤0.01% 1584
2022
Q3
$2.91M Buy
44,186
+3,211
+8% +$212K 0.01% 1219
2022
Q2
$2.07M Buy
40,975
+7,601
+23% +$384K ﹤0.01% 1420
2022
Q1
$2.13M Sell
33,374
-263
-0.8% -$16.8K ﹤0.01% 1449
2021
Q4
$3.6M Buy
33,637
+5,969
+22% +$639K 0.01% 1184
2021
Q3
$2.85M Buy
27,668
+7,281
+36% +$749K 0.01% 1280
2021
Q2
$1.79M Buy
20,387
+525
+3% +$46.2K ﹤0.01% 1537
2021
Q1
$1.93M Sell
19,862
-6,787
-25% -$660K ﹤0.01% 1424
2020
Q4
$2.99M Sell
26,649
-7,925
-23% -$889K 0.01% 1071
2020
Q3
$3.21M Sell
34,574
-3,884
-10% -$360K 0.01% 948
2020
Q2
$3M Sell
38,458
-1,486
-4% -$116K 0.01% 935
2020
Q1
$2.34M Buy
39,944
+19,120
+92% +$1.12M 0.01% 822
2019
Q4
$1.67M Buy
20,824
+18,046
+650% +$1.45M 0.01% 1250
2019
Q3
$204K Sell
2,778
-403
-13% -$29.6K ﹤0.01% 2492
2019
Q2
$300K Buy
+3,181
New +$300K ﹤0.01% 2274
2017
Q3
Sell
-10,360
Closed -$525K 2526
2017
Q2
$525K Buy
+10,360
New +$525K ﹤0.01% 1647